首页> 外文期刊>Journal of Drug Delivery and Therapeutics >DEVELOPMENT, CHARACTERIZATION & STABILIZATION OF POORLY WATER SOLUBLE DRUGS UTILIZING SOLID DISPERSION TECHNIQUES BY USING Β - CYCLODEXTRIN
【24h】

DEVELOPMENT, CHARACTERIZATION & STABILIZATION OF POORLY WATER SOLUBLE DRUGS UTILIZING SOLID DISPERSION TECHNIQUES BY USING Β - CYCLODEXTRIN

机译:Β-环糊精利用固体分散技术开发,表征和稳定水溶性药物。

获取原文
           

摘要

Telmisartan (TLM) is an angiotensin II receptor antagonist used in the treatment of hypertension. According to BCS (biopharmaceutical classification system) Telmisartan belongs to class II drug, and it is practically insoluble in water and it shows low dissolution profile and poor absorption. The present study is to improve the solubility of Telmisartan by forming complexation with β- CD by using four convenient methods viz physical mixing method, kneading method, and solvent evaporation fusion method at different molar ratios of 1:1, dissolution studies were carried out in pH 7.4 phosphate buffer. The cyclodextrin complexes formulated by employing 1:1 (drug: complexing agent) with kneading technique showed higher drug release.
机译:替米沙坦(TLM)是一种用于治疗高血压的血管紧张素II受体拮抗剂。根据BCS(生物药物分类系统),替米沙坦属于II类药物,实际上不溶于水,并且溶出度低,吸收差。本研究通过四种简便的方法-物理混合法,捏合法和溶剂蒸发熔融法在1:1的不同摩尔比下与β-CD形成络合物来提高替米沙坦的溶解度。 pH 7.4磷酸盐缓冲液。通过采用1:1(药物:络合剂)和捏合技术配制的环糊精复合物显示出更高的药物释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号